BPH With Symptomatic Lower Urinary Tract Symptoms
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
ProVerum MedicalIreland - Dublin
2 programsProVee Urethral Expander SystemN/A1 trial
ProVee deviceN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
2028
2029
ProVerum MedicalProVee device
ProVerum MedicalProVee Urethral Expander System
Clinical Trials (2)
Total enrollment: 261 patients across 2 trials
ProVIDE II Bridging Study
Start: Mar 2024Est. completion: Jun 202940 patients
N/AActive Not Recruiting
ProVee Urethral Expander System IDE Study (ProVIDE)
Start: Jun 2022Est. completion: Dec 2028221 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.